• [1]
    Lanchares, J.L., Hernandez, M.L. (2000) Recurrent vaginal candidiasis: changes in etiopathogenical patterns. Int. J. Gynecol. Obstet. 71, S29S35.
  • [2]
    Ng, K.P., Madasamy, M., Saw, T.L., Baki, A., He, J., Soo-Hoo, T.J. (1999) Candida biotypes isolated from clinical specimens in Malaysia. Mycopathologia 144, 135140.
  • [3]
    Boschman, C.R., Bodnar, U.R., Tornatore, M.A., Obias, A.A., Noskin, G.A., Englund, K., Postelnick, M.A., Suriano, T., Peterson, L.R. (1998) Thirteen-year evolution of azole resistance in yeast isolates and prevalence of resistant strains carried by cancer patients at a large medical center. Antimicrob. Agents Chemother. 42, 734738.
  • [4]
    Prasad, R., Kapoor, K. (2005) Multidrug resistance in yeast Candida. Int. Rev. Cytol. 242, 215248.
  • [5]
    Sanglard, D., Ischer, F., Koymans, L., Bille, J. (1998) Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob. Agents Chemother. 42, 241253.
  • [6]
    Henry, K.W., Nickels, J.T., Edlind, T.D. (2000) Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors Antimicrob. Agents Chemother. 44, 26932700.
  • [7]
    Sanglard, D., Ischer, F., Monod, M., Bille, J. (1997) Cloning of Candida albicans genes conferring resistance of azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143, 405416.
  • [8]
    Sanglard, D., Kuchler, K., Pagani, J.L., Monod, M., Bille, J. (1995) Mechanism of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39, 23782386.
  • [9]
    Niimi, M., Niimi, K., Takano, Y., Holmes, A.R., Fischer, F.J., Uehara, Y., Cannon, R.D. (2004) Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance. J. Antimicrob. Chemother. 54, 9991006.
  • [10]
    Pelletier, R., Peter, J., Antin, C., Gonzalez, C., Wood, L., Walsh, T.J. (2000) Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations. J. Clin. Microbiol. 38, 15631568.
  • [11]
    Maebashi, K., Niimi, M., Kudoh, M., Fischer, F.J., Makimura, K., Niimi, K., Piper, R.J., Uchida, K., Arisawa, M., Cannon, R.D., Yamaguchi, H. (2001) Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients. J. Antimicrob. Chemother. 47, 527536.
  • [12]
    Albertson, G.D., Niimi, M., Cannon, R.D., Jenkinson, H.F. (1996) Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob. Agents Chemother. 40, 28352841.
  • [13]
    Morschhauser, J. (2002) The genetic basis of fluconazole resistance development in Candida albicans. Biochim. Biophys. Acta 1587, 240248.
  • [14]
    Odds, F.C. (1996) Resistance of clinically important yeasts to antifungal agents. Int. J. Antimicrob. Agents 6, 145147.
  • [15]
    Franz, R., Kelly, S.L., Lamb, D.C., Kelly, D.E., Ruhnke, M., Morshhauser, J. (1998) Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance to azole. J. Med. Vet. Mycol. 25, 329333.
  • [16]
    White, T.C. (1997) Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole ressitance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 41, 14821487.
  • [17]
    Lyons, C.N., White, T.C. (2000) Transcriptional analyses of antifungal drug resistance in Candida albicans. Antimicrob. Agents Chemother. 44, 22962303.
  • [18]
    Hampsey, M. (1998) Molecular genetics of the RNA Polymerase II general transcriptional machinery. Microbiol. Mol. Biol. Rev. 62, 465503.
  • [19]
    de Micheli, M., Bille, J., Schueller, C., Sanglard, D. (2002) A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance. Mol. Microbiol. 43, 11971214.
  • [20]
    Asai, K., Tsuchimori, N., Okonogi, K., Perfect, J.R., Gotoh, O., Yoshida, Y. (1999) Formation of azole-resistant Candida albicans by mutation of sterol 14-demethylase P450. Antimicrob. Agents Chemother. 43, 11631169.
  • [21]
    Harry, J.B., Song, J.L., Lyons, C.N., White, T.C. (2002) Transcription initiation of genes associated with azole resistance in Candida albicans. Med. Mycol. 40, 7381.